PT - JOURNAL ARTICLE AU - Mboowa, Gerald AU - Matteson, Nathaniel Lucero AU - Tanui, Collins Kipngetich AU - Kasonde, Mpanga AU - Kamwiziku, Guyguy Kusanzangana AU - Akanbi, Olusola Anuoluwapo AU - Chitio, Jucunú Johane Elias AU - Kagoli, Mathews AU - Essomba, René Ghislain AU - Ayitewala, Alisen AU - Ssewanyana, Isaac AU - Ngo Bitoungui, Valentina Josiane AU - Amuri, Adrienne Aziza AU - Azman, Andrew S AU - Babatunde, Olajumoke Atinuke AU - Akenji, Blaise Mboringong AU - Broban, Anaïs AU - Malembaka, Espoir Bwenge AU - Ongole, Francis AU - Chukwu, Chimaobi Emmanuel AU - Ismael, Nália AU - Kapona, Otridah AU - Laurindo, Osvaldo AU - Mbala, Placide Kingebeni AU - Etoundi Mballa, Georges Alain AU - Miambo, Imelda Carlos Zulfa AU - Mwanyongo, Alex Ansaye AU - Najjuka, Grace AU - Mutale, Joseph AU - Musonda, Kunda AU - Niyonzima, Allan Muruta AU - Nyenje, Mirriam Ethel AU - Popoola, Michael AU - Shempela, Doreen Mainza AU - Medi Sike, Christiane AU - Sitoe, Sofião Manjor AU - Wanjohi, Dorcas Waruguru AU - Welo, Placide Okitayemba AU - Yelewa, Mtisunge AU - Yennan, Sebastian AU - Ziba, Lucius AU - CholGEN Consortium AU - Bitilinyu-Bangoh, Joseph Ephram AU - Chilengi, Roma AU - Hadja, Hamsatou AU - Idris, Jide AU - Langa, José Paulo Maurício AU - Mukadi-Bamuleka, Daniel AU - Nabadda, Susan AU - Debes, Amanda K AU - Sack, David A AU - Kaseya, Jean AU - Tebeje, Yenew Kebede AU - Wohl, Shirlee AU - Tessema, Sofonias Kifle TI - Multicountry genomic analysis underscores regional cholera spread in Africa AID - 10.1101/2024.11.15.24317392 DP - 2024 Jan 01 TA - medRxiv PG - 2024.11.15.24317392 4099 - http://medrxiv.org/content/early/2024/11/15/2024.11.15.24317392.short 4100 - http://medrxiv.org/content/early/2024/11/15/2024.11.15.24317392.full AB - Cholera remains a significant public health burden in many countries in sub-Saharan Africa, though the exact mechanisms of bacterial emergence and spread remain largely undefined. We generated genomic data from 728 Vibrio cholerae O1 isolates predominantly collected between 2019-2024 to create the largest dataset of V. cholerae genomes sequenced locally in Africa. This dataset enabled us to interrogate recent patterns of spread, including the rapid circulation of the AFR15 lineage associated with unusually large outbreaks in Southern Africa. We provide evidence for the movement of the AFR15 lineage into new African Member States and confirm previously observed differences in V. cholerae transmission dynamics in West versus East Africa, though cross-border transmission is prevalent on both sides of the continent. Despite observed differences, evolutionary processes are similar across lineages and we find no evidence for significant changes in antimicrobial resistance genotypes. Overall, our findings emphasize the importance of regionally coordinated cross-border surveillance and interventions, while also demonstrating the critical role of locally generated genomic data in understanding the spread of cholera in Africa.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Bill & Melinda Gates Foundation (INV-047157 and INV-047156).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This research utilized samples collected through routine national surveillance programs and all data and samples were anonymized to ensure the privacy and confidentiality of the individuals involved. The use of these samples was approved by respective Ethical Review Boards/Institutions in each country, ensuring that the research adhered to the highest ethical standards and legal requirements. In Cameroon, ethical approval was granted by the National Committee on Ethics in Research for Human Health (2024/02/1640/CE/CNERSH/SP). In DRC, ethical approval was granted by the Board of the Ethics Committee of the School of Public Health at the University of Kinshasa (ESP/CE/148/2023 and ESP/CE/149/2023). In Malawi, this work was approved by the National Health Sciences Research Committee (Protocol #867). In Mozambique, ethical approval was granted by the National Bioethics Committee for Health (335/CNBS/23). In Nigeria, ethical approval was not required as it is based on data from Nigeria's national surveillance program, collected by the Nigeria Centre for Disease Control. In Uganda, ethical approval was granted by the Uganda Ministry of Health National Health Laboratory Services (UNHL-2024-88).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesRaw sequencing reads are available on NCBI under the BioProject accession ID PRJNA1145341 and Sequence Read Archive accession IDs are provided in Supplemental Data 1. Accession IDs for the publicly available sequences acquired from NCBI or VibrioWatch are provided in Supplemental Data 2. https://github.com/CholGen/RegionalAnalysis-2024 https://doi.org/10.5281/zenodo.14170938